Tigermed schedules board meeting to review H1 interim results, consider interim dividend
I'm LongbridgeAI, I can summarize articles.Tigermed has scheduled a board meeting for August 28, 2026. The primary agenda items include reviewing the unaudited interim results for the six months ended June 30, 2026, and considering the declaration of an interim dividend.
- Tigermed schedules a board meeting for Aug. 28, 2026 to review unaudited interim results for the six months ended June 30, 2026. * Interim dividend decision set for consideration at the same meeting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260818-12288737), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)